Back to Search Start Over

Biohaven bounces back with phase 3 ultra-rare disease win, heads to FDA in bid to overturn prior refusal.

Authors :
Taylor, Nick Paul
Source :
FierceBiotech; 9/23/2024, pN.PAG-N.PAG, 1p
Publication Year :
2024

Abstract

Biohaven has [ABSTRACT FROM AUTHOR]

Subjects

Subjects :
RARE diseases
CLINICAL trials
DRUGS

Details

Language :
English
Database :
Complementary Index
Journal :
FierceBiotech
Publication Type :
Periodical
Accession number :
179812196

Tools

Authors Abstract Subjects Details